Literature DB >> 26414225

Neutropenic Enterocolitis: New Insights Into a Deadly Entity.

Taha Sachak1, Michael A Arnold, Bita V Naini, Rondell P Graham, Sejal S Shah, Michael Cruise, Jason Y Park, Lindsey Clark, Laura Lamps, Wendy L Frankel, Nicole Theodoropoulos, Christina A Arnold.   

Abstract

Neutropenic enterocolitis (NE) is a deadly ileocecal-based disease seen in patients with a recent history of chemotherapy. As histology is not included in the current diagnostic criteria, the pathologic features of NE are poorly understood. We undertook a multi-institutional study of NE, and report helpful clinical clues, such as immunosuppression (n=20/20), recent chemotherapy (n=17/18), neutropenia (n=16/18) gastrointestinal symptoms (n=19/19), abnormal imaging studies of the cecum/right colon (n=11/14), and positive microbiological studies (n=13/15). Fever (n=9/15) and sepsis (n=8/16) were also common. Pathologically, the cecum/right colon was always involved (n=17/17), but findings were identified in other bowel segments as well. NE lesions consisted of patchy necrosis (n=18/20), infiltrating organisms (n=17/20), hemorrhage (n=15/20), ulcer (n=15/19), edema (n=15/20), and depletion of inflammatory cells (n=15/20). Seventy-nine percent (n=15/19) of patients with histologically confirmed NE died: 47% (n=7/15) of these deaths were attributed to NE and the remainder to the patients' underlying conditions. Importantly, we observed a clinical diagnostic discordancy rate of 35% (n=9/26): 15% (n=3/20) of histologically confirmed NE were clinically unsuspected, and 26% (n=6/23) of clinically suspected NE represented a different disease process. Alternative diagnoses included unspecified colitis, infection, graft-versus-host disease, relapsed malignancy, mycophenolate injury, appendicitis, and ischemia. The causes of death in patients with NE mimics included unrecognized appendicitis and unrecognized graft-versus-host disease. To improve diagnostic accuracy, we propose that histology be required for a diagnosis of "definitive NE," with other clinically suspicious cases reported as "suspicious for NE" until all other possible diagnoses have been reasonably excluded.

Entities:  

Mesh:

Year:  2015        PMID: 26414225     DOI: 10.1097/PAS.0000000000000517

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

Review 1.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

2.  Painless neutropenic enterocolitis in a patient undergoing chemotherapy.

Authors:  E J Chow; K D Bishop
Journal:  Curr Oncol       Date:  2016-10-25       Impact factor: 3.677

Review 3.  The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.

Authors:  Elie Azoulay; Peter Schellongowski; Michael Darmon; Philippe R Bauer; Dominique Benoit; Pieter Depuydt; Jigeeshu V Divatia; Virginie Lemiale; Maarten van Vliet; Anne-Pascale Meert; Djamel Mokart; Stephen M Pastores; Anders Perner; Frédéric Pène; Peter Pickkers; Kathryn A Puxty; Francois Vincent; Jorge Salluh; Ayman O Soubani; Massimo Antonelli; Thomas Staudinger; Michael von Bergwelt-Baildon; Marcio Soares
Journal:  Intensive Care Med       Date:  2017-07-19       Impact factor: 17.440

Review 4.  Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Authors:  M Schmidt-Hieber; J Bierwirth; D Buchheidt; O A Cornely; M Hentrich; G Maschmeyer; E Schalk; J J Vehreschild; Maria J G T Vehreschild
Journal:  Ann Hematol       Date:  2017-11-24       Impact factor: 3.673

Review 5.  New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury.

Authors:  Marika Cinausero; Giuseppe Aprile; Paola Ermacora; Debora Basile; Maria G Vitale; Valentina Fanotto; Giuseppe Parisi; Lorenzo Calvetti; Stephen T Sonis
Journal:  Front Pharmacol       Date:  2017-06-08       Impact factor: 5.810

6.  Neutropenic Enterocolitis in a Pediatric Heart Transplant Recipient on Multiple Immunosuppressants.

Authors:  Emily E Miller; Leigh Christopher Reardon
Journal:  Case Rep Transplant       Date:  2018-05-08

Review 7.  The prognostic impact of abdominal surgery in cancer patients with neutropenic enterocolitis: a systematic review and meta-analysis, on behalf the Groupe de Recherche en Réanimation Respiratoire du patient d'Onco-Hématologie (GRRR-OH).

Authors:  Colombe Saillard; Lara Zafrani; Michael Darmon; Magali Bisbal; Laurent Chow-Chine; Antoine Sannini; Jean-Paul Brun; Jacques Ewald; Olivier Turrini; Marion Faucher; Elie Azoulay; Djamel Mokart
Journal:  Ann Intensive Care       Date:  2018-04-19       Impact factor: 6.925

8.  Neutropenic enterocolitis: A clinico-pathological review.

Authors:  Rong Xia; Xuchen Zhang
Journal:  World J Gastrointest Pathophysiol       Date:  2019-10-15

Review 9.  Neutropenic Enterocolitis and Sepsis: Towards the Definition of a Pathologic Profile.

Authors:  Giuseppe Bertozzi; Aniello Maiese; Giovanna Passaro; Alberto Tosoni; Antonio Mirijello; Stefania De Simone; Benedetta Baldari; Luigi Cipolloni; Raffaele La Russa
Journal:  Medicina (Kaunas)       Date:  2021-06-20       Impact factor: 2.430

10.  Neutropenic Enterocolitis in the Treatment of Solid Tumors: A Case Report and Review of the Literature.

Authors:  Sara Cherri; Tiziana Prochilo; Luigina Rota; Stefano Mutti; Marco Garatti; Barbara Liserre; Alberto Zaniboni
Journal:  Case Rep Oncol       Date:  2020-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.